APGE Apogee Therapeutics, Inc.

HealthcareBiotechnology
$81.81
3.23%
39
QScore Signal
Short
Confidence: MEDIUM
Long-Term
30
Short-Term
48

Value

30
P/E-19.41
8
P/B5.49
44
P/S0.00
70
EV/EBITDA-17.77
5

Growth

36
Revenue Growth0.0%
28
EPS Growth-27.9%
41
FCF Growth-35.0%
40

Momentum

80
12-Month Return130.0%
100
3-Month Return31.7%
100
1-Month Return-1.6%
50
RSI (14)26.31
60
50/200 MABullish
75

Profitability

19
ROE-36.8%
44
ROA-27.3%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-4.6%
0

Risk

25
Beta0.69
55
60-Day Volatility57.2%
0

Generated 5/7/2026, 10:50:07 PM · How is this calculated?

QScore Analysis